Take them, and consider increasing your intake
Available from: Pharmacoeconomic Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adults patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet]
Coupling with drugs, fluorescent tracers or various targeting molecules can significantly change the physico-chemical properties and the intracellular fate of the nanocarriers [28, 51]
Preclinical research has investigated BPC-157 for a wide range of applications, including gastrointestinal healing (ulcers, NSAID-induced gut damage, intestinal permeability), tendon and ligament repair, muscle recovery from crush injuries, peripheral nerve regeneration, and neuroprotection